Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-03

Clinical Trial Update: Study to Assess Function and Satisfaction of Oral Ubrogepant in Adult Participants After Multiple Migraine Attacks In Canada

View source ↗

Summary

This clinical trial update covers a Canada-based study assessing function and satisfaction after multiple migraine attacks with oral ubrogepant in adults. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ubrelvy (ubrogepant)

Snippet

Sponsor: AbbVie | Conditions: Migraine | Status: ACTIVE_NOT_RECRUITING